Extracellular Vesicle Isolation With Charge-and-Size Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating and characterizing extracellular vesicles (EVs) face challenges in sensitivity, specificity, quantitative accuracy, and dynamic range, particularly when dealing with complex source matrices, and lack the ability to efficiently separate high-abundance free plasma proteins and fractionate EVs into subpopulations.
Innovation Solution
A multi-dimensional chromatography approach is employed, utilizing two or more different types of chromatography, such as charge-based and size exclusion chromatography, to isolate, purify, and fractionate EVs based on differences in surface charge, size, and composition, allowing for the separation of EV subpopulations and reducing sample complexity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If ultracentrifugation and size exclusion chromatography are used for EV isolation, then EVs can be recovered from plasma, but high-abundance free plasma proteins cannot be effectively separated from EVs
Solution Approach 1:
The patent divides the EV isolation process into multiple sequential steps: pre-concentration (ultracentrifugation), charge-based chromatography separation, and size exclusion chromatography fractionation. This segmentation allows each step to optimize for specific goals - recovery in pre-concentration, purity in charge-based separation, and subpopulation resolution in size exclusion, thereby resolving the contradiction between EV recovery and separation purity.
Solution Approach 2:
The patent transitions from single-mode separation to multi-dimensional chromatography by combining charge-based separation (anion exchange) with size exclusion chromatography. This dimensional expansion enables simultaneous separation of EVs from plasma proteins based on charge differences and subsequent fractionation by size, achieving both high purity and subpopulation resolution that single methods cannot achieve alone.
2Quantity of substance
If conventional plasma proteomics is used, then plasma proteins can be analyzed, but the high dynamic range and high-abundance free plasma proteins compromise biomarker identification
Solution Approach 1:
The patent extracts and removes high-abundance free plasma proteins from the EV population through charge-based anion exchange chromatography, which selectively binds and separates EVs from plasma proteins based on charge differences. This extraction step reduces the dynamic range of the sample, enabling sensitive detection and accurate identification of low-abundance EV biomarkers that would be masked in conventional plasma proteomics.
Solution Approach 2:
The patent performs preliminary charge-based chromatography separation before size exclusion chromatography and mass spectrometry analysis. This preliminary action pre-concentrates EVs and removes interfering plasma proteins, creating an optimized sample matrix that enhances the sensitivity and accuracy of downstream biomarker identification in the mass spectrometry step.
3Device complexity
If single-mode chromatography is used for EV isolation, then the method is simple, but EV subpopulations cannot be fractionated into distinct groups
Solution Approach 1:
The patent segments the EV population into distinct subpopulations by performing sequential chromatography steps: first charge-based anion exchange chromatography to separate EVs from plasma proteins, then size exclusion chromatography to fractionate EV subpopulations based on size and composition. This segmentation enables identification of functionally distinct EV subsets (e.g., exosomes, microvesicles) with unique biomarker profiles.
Solution Approach 2:
The patent adds another dimension of separation by combining charge-based chromatography with size exclusion chromatography. The charge-based step separates EVs based on surface charge properties, and the subsequent size exclusion step further fractionates them by size and composition. This multi-dimensional approach enables detailed EV subpopulation resolution while maintaining operational simplicity through standardized chromatographic techniques.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enhances the purity and specificity of EV populations, enabling more accurate proteomic analysis and facilitating the identification of EV-associated biomarkers for diagnosis and prognosis of diseases like prostate cancer, improving the efficiency of EV-based diagnostics.
Implementation Method 1
The two or more different types of chromatography can be based on different modes of separation, such as separation by charge in one mode and separation by size in another mode
Implementation Method 2
The two or more different types of chromatography can be based on different modes of separation, such as separation by charge in one mode and separation by size in another mode
Data Source
AI summary
Methods are provided for isolation, purification, enrichment, and/or fractionation of extracellular vesicles (EVs) using a multi-dimensional chromatography approach. The use of two or more different types of chromatography, either sequentially or simultaneously, yields superior removal of extraneous proteins and fractionation into sub-populations of EVs. The two or more different types of chromatography can be based on different modes of separation, such as separation by charge and by size, or can be separation by size using different size ranges. Analysis of the obtained EVs, such as by proteomics through mass spectrometry, can be used to diagnose a disease or medical condition based on EV-associated biomarkers.